Citation: | ZHAO Xu-ran, GAO Jin-e, NA Ri-song, HAI Rong, ZHANG Peng-fei. Clinical study on the correlation between sarcopenic obesity and hypertension in elderly subjects[J]. Chinese Journal of General Practice, 2022, 20(11): 1874-1877. doi: 10.16766/j.cnki.issn.1674-4152.002724 |
[1] |
李静, 范利, 华琦, 等. 中国老年高血压管理指南2019[J]. 中华高血压杂志, 2019, 27(2): 111-135. doi: 10.16439/j.cnki.1673-7245.2019.02.008
LI J, FAN L, HUA Q, et al. 2019 Chinese guidelines for the management of hypertension in the elderly[J]. Chinese Journal of Cardiovascular Medicine, 2019, 27(2): 111-135. doi: 10.16439/j.cnki.1673-7245.2019.02.008
|
[2] |
吉彤, 汤哲, 李耘, 等. 老年人少肌性肥胖的诊断标准现况[J]. 实用老年医学, 2021, 35(1): 74-76. doi: 10.3969/j.issn.1003-9198.2021.01.020
JI T, TANG Z, LI Y, et al. Status of diagnostic criteria for sarcopenic obesity in the elderly[J]. Practical Geriatrics, 2021, 35(1): 74-76. doi: 10.3969/j.issn.1003-9198.2021.01.020
|
[3] |
KREIDIEH D, ITANI L, El MASRI D, et al. Association between sarcopenic obesity, type 2 diabetes, and hypertension in overweight and obese treatment-seeking adult women[J]. J Cardiovasc Dev Dis, 2018, 5(4): 51-58. doi: 10.3390/jcdd5040051
|
[4] |
CHEN L K, WOO J, ASSANTACHAI P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020, 21(3): 300-307. doi: 10.1016/j.jamda.2019.12.012
|
[5] |
刘莹, 谭寅凤, 张金月, 等. 超重肥胖和正常体重人群肠道菌群的差异分析[J]. 中国临床研究, 2022, 35(1): 21-24. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK202201005.htm
LIU Y, TAN Y F, ZHANG J Y, et al. Difference of gut microbiota in people with overweight/obese and normal weight[J]. Chinese Journal of Clinical Research, 2022, 35(1): 21-24. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGCK202201005.htm
|
[6] |
DONINI L M, BUSETTO L, BAUER J M, et al. Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review[J]. Clin Nutr, 2020, 39(8): 2368-2388. doi: 10.1016/j.clnu.2019.11.024
|
[7] |
PONTI F, SANTORO A, MERCATELLI D, et al. Aging and imaging assessment of body composition: From fat to facts[J]. Front Endocrinol(Lausanne), 2020, 10(1): 861-878.
|
[8] |
ZHANG X, XIE X, DOU Q, et al. Association of sarcopenic obesity with the risk of all-cause mortality among adults over a broad range of different settings: A updated meta-analysis[J]. BMC Geriatr, 2019, 19(1): 183-197. doi: 10.1186/s12877-019-1195-y
|
[9] |
HONG S H, CHOI K M. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences[J]. Int J Mol Sci, 2020, 21(2): 494-511. doi: 10.3390/ijms21020494
|
[10] |
POLYZOS S A, MARGIORIS A N. Sarcopenic obesity[J]. Hormones (Athens), 2018, 17(3): 321-331. doi: 10.1007/s42000-018-0049-x
|
[11] |
ATKINS J L, WANNAMATHEE S G. Sarcopenic obesity in ageing: Cardiovascular outcomes and mortality[J]. Br J Nutr, 2020, 124(10): 1102-1113. doi: 10.1017/S0007114520002172
|
[12] |
BAI T, FANG F, LI F, et al. Sarcopenia is associated with hypertension in older adults: A systematic review and meta-analysis[J]. BMC Geriatr, 2020, 20(1): 279-288. doi: 10.1186/s12877-020-01672-y
|
[13] |
SASAKI K I, FUKUMOTO Y. Sarcopenia as a comorbidity of cardiovascular disease[J]. J Cardiol, 2022, 79(5): 596-604. doi: 10.1016/j.jjcc.2021.10.013
|
[14] |
马璐瑶, 林萍, 王琴, 等. 老年慢性心力衰竭患者肌少症的筛查及干预研究[J]. 中华全科医学, 2022, 20(3): 419-423. doi: 10.16766/j.cnki.issn.1674-4152.002367
MA L Y, LIN P, WANG Q, et al. Screening and intervention of sarcopoenia in elderly patients with chronic heart failure[J]. Chinese Journal of General Practice, 2022, 20(3): 419-423. doi: 10.16766/j.cnki.issn.1674-4152.002367
|
[15] |
PASDAR Y, DARBANDI M, REZAEIAN S, et al. Association of obesity, sarcopenia, and sarcopenic obesity with hypertension in adults: A cross-sectional study from Ravansar, Iran during 2014-2017[J]. Front Public Health, 2022, 9: 705055. DOI: 10.3389/fpubh.2021.705055.
|
[16] |
ZAMBONI M, RUBELE S, ROSSI A P. Sarcopenia and obesity[J]. Curr Opin Clin Nutr Metab Care, 2019, 22(1): 13-19. doi: 10.1097/MCO.0000000000000519
|
[17] |
LIVSHITS G, KALINKOVICH A. Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis[J]. Ageing Res Rev, 2019, 56(8): 100980. DOI: 10.1016/j.arr.2019.100980.
|
[18] |
GUARALDI G, MILIC J, SEBASTIANI G, et al. Sarcopenic obesity at the crossroad of pathogenesis of cardiometabolic diseases[J]. Atherosclerosis, 2021, 335(10): 84-86.
|
[19] |
SUN T, MA Z, GAO L, et al. Correlation between sarcopenia and arteriosclerosis in elderly community dwellers: A multicenter study[J]. J Nutr Health Aging, 2021, 25(5): 692-697. doi: 10.1007/s12603-021-1624-4
|
[20] |
TAKAHASHI F, HASHIMOTO Y, KAJI A, et al. Sarcopenic obesity is associated with macroalbuminuria in patients with type 2 diabetes: A cross-sectional study[J]. Endocr J, 2021, 68(7): 781-789. doi: 10.1507/endocrj.EJ20-0655
|
[21] |
EVANS K, ABDELHAFIZ D, ABDELHAFIZ A H. Sarcopenic obesity as a determinant of cardiovascular disease risk in older people: A systematic review[J]. Postgrad Med, 2021, 133(8): 831-842. doi: 10.1080/00325481.2021.1942934
|
[22] |
LIM H S, PARK Y H, SUH K, et al. Association between sarcopenia, sarcopenic obesity, and chronic disease in Korean elderly[J]. J Bone Metab, 2018, 25(3): 187-193. doi: 10.11005/jbm.2018.25.3.187
|